In the United States, six states sued OxyContin, an opioid manufacturer, on Tuesday for using fraudulent marketing to increase drug sales, which exacerbated opioid overdose.
According to a civil lawsuit filed by the Nevada State Court in Las Vegas, pharmaceutical company Purdue Pharmaceuticals has minimized the risks and exaggerated benefits of long-term use of narcotic opioids.
Nevada Attorney General Adam Raksarte stated in a statement: “The fraud at Purdue University has concealed the owner’s pocket and caused the deaths and hospitalization of thousands of Nevada’s people.
In Florida, North Carolina, North Dakota, Tennessee, and Texas filed similar unfair and fraudulent trade action lawsuits.
In Tennessee, Attorney General Herbert Slatery claimed that Purdue and his state violated the 2007 settlement agreement, “knowing that the patient died because of overdose, and that his drug was illegally sold to non-patients.”
Purdue University in Stamford, Connecticut, denied these claims and stated that it would defend itself.
Company spokesperson Bob Joseph said in an e-mail statement that these lawsuits were carried out after several months of negotiations with state officials to resolve the opium crisis. He said that the lawsuit marked an expensive and lengthy lawsuit.
Slatery, who heads 40 countries investigating opioid manufacturers and distributors, said that his state’s complaints were filed in Knoxville with a temporary seal to protect the confidentiality of Purdue’s information provided to investigators.
Leigh Ann Apple Jones, spokesperson for Slatery, said the investigation and negotiations with the company are continuing.
In Florida, Attorney General Pambundy added four other opioid manufacturers and four distributors to complaints in her state.
Bondi said in a statement: “We are in the middle of a national opioid crisis. There are 175 people killed every day in the country and 15 people live in Florida every day. She accuses these companies of “taking in the pain and suffering of Florida people. Lee.”
Laxalt of Nevada accused Putin Pharmaceuticals of abandoning the risk of serious addiction and exaggerating the effectiveness of doctors’ ability to deal with patient addiction.
In Texas, Attorney General Ken Paxton also claimed that the company distorts their opioids without the “highest dose” and that doctors and patients may increase their doses indefinitely without risk.
In North Carolina, State Attorney General Joshstein blamed Purdue Pharmaceuticals for denigrating non-opioid analgesics such as aspirin and ibuprofen without scientific evidence.
The lawsuit took place approximately one month after the replacement of a federal judge in Cleveland. He encouraged the company and the state government to resolve hundreds of lawsuits brought by local governments and accused them of excessive use of prescription opioid painkillers.
The judge will arrange three trials in Ohio from next year.
After purchasing $19.5 million in compensation in 2007, Purdue Pharmaceuticals did not admit to having committed a wrongdoing because it had litigation with 26 states and the District of Columbia after being accused of aggressively marketing OxyContin to doctors while reducing the risk of addiction. Reconciliation. Nevada, North Carolina, Tennessee and Texas are part of the agreement. Florida and North Dakota are not.
Source: ABC News